Morning Insight

Transcription

Morning Insight
Morning Insight
15 April 2015
For private circulation only
Global Economies and Equities
 This morning the Asian stock indices have posted mixed performance – Chinese data on




its exports and GDP growth have led to some of the Asian equity indices to fall while
Chinese indices are in significantly positive territory;
China’s March exports fell 15% yoy while its imports fell 12.7%, which is the sharpest
rate since 2009. Due to poor performance on both exports and imports, there were
worries on China’s January-March GDP growth rate. However, China reported this
morning 7% GDP growth for this first quarter of 2015. This 7% growth is the weakest
expansion since 2009 – however, in our view, as long as China maintains its growth at 7%,
there may not be serious setback to the global equities.
The World Bank cut its 2015 growth forecasts for developing East Asia and China,
and warned of "significant" risks from global uncertainties including the potential
impact from a strengthening dollar and higher U.S. interest rates. It expects the
developing East Asia and Pacific (EAP) region, which includes China, to grow 6.7% in
each of 2015 and 2016, down from 6.9% growth in 2014. That's down from its
previous forecast in October of 6.9% growth this year and 6.8% in 2016;
Singapore joined regional peers in refraining from easing monetary policy further after
economic growth last quarter beat analysts’ estimates. GDP rose an annualized
1.1% in the three months through March from the previous quarter;
Oil production from the fastest-growing U.S. shale plays is set to fall some 45,000
barrels per day to 4.98 million bpd in May from April, the first monthly decline in
over four years, projections from the U.S. Energy Information Administration
showed on Monday. The projected slip from 5.02 million bpd in April underscores how
record crude production from the U.S. shale boom may be backtracking after global
markets saw prices effectively slashed by 60% since June on oversupply and lacklustre
demand;
Indian Economy and the Equity Markets
 The domestic market gained strength in last couple of hours of trade on Monday





with the equity benchmarks closing at more than one month high ahead of JanuaryMarch quarter earnings. The BSE Sensex closed above the 29,000- mark, up 165 points at
29,044, the highest level since March 5. The NSE Nifty index reclaimed 8,800 level,
climbing 54 points to close at 8,834. Both the FIIs & DIIs were net buyers of stock worth
Rs.417.01 crore & 46.42 crore respectively;
The World Bank has said India continues to be the leading nation in remittances
pulling in $70 billion from its global migrant workforce in 2014. “Total remittances
in 2014 reached $ 583 billion. While India received $ 70 billion, China $ 64 billion and
the Philippines $28 billion;
Retail inflation, as measured by the consumer price index (CPI), slowed to 5.17%
year-on-year in March, compared to 5.37% in February. The fall was largely broadbased with food inflation, which constitutes nearly half the index, coming in at 6.14%
compared to 6.79% in February, clothing and footwear slowed to 6.27% yoy from 6.38%,
though fuel and light inflation perked up a bit;
S&P warns that India’s fiscal balance is vulnerable to financial or commodity risk;
Mutual funds pumped in over Rs.40,000 crore in equity markets in FY2015, making
it their first net inflow in six years for an entire fiscal. It should be noted that they
pulled out over Rs.14,000 crore in the preceding financial year, FY2014;
The World Bank has predicted that India’s GDP growth would outperform that of
China in both 2015 and 2016. While it expects China to grow at 7.1% and 7%, India is
estimated to grow at 7.5% and 7.9% respectively in 2015 and 2016;
Founder &
Managing Director
[email protected]
Equinomics Research & Advisory Private Limited - Investment Adviser
15 April 2015
Equinomics
Morning Insight
|
Indian Economy (Continued)
 The RBI has been quite aggressively buying dollar from the spot markets – it has purchased $49.2 billion of
dollar from the spot markets during the first 10 months (April-February) of FY2015. In our view, this is the
brilliant move and it would help the economy in any possible event of pull out by the FIIs from the Indian debt or
equity markets;
We initiate our “BUY” recommendation on Bambino Agro Industries Ltd.
Bambino Agro Industries Limited (Bambino) is more than 3 decades old a small FMCG company engaged in
manufacturing vermicelli, macaroni and other pasta products at its manufacturing units located in Bibinagar- Andhra
Pradesh, Gurgaon-Haryana and at Indore -Madhya Pradesh. Over the years, Bambino has emerged as a market leader
in the pasta industry. The installed capacity of the company as on date stands at 1,30,460 tonnes p.a and products are
sold under the Brand name “Bambino” acquiring enviable reputation in domestic and overseas markets. Bambino has
a wide distribution network for selling the products.
Though Bambino is more than 3 decade old company, it still remains as a small FMCG company with a turnover of
Rs.262 crore in FY2014 (year end September). However, in the last 5 years it started growing significantly – while its
net sales have grown significantly. While its net sales have grown by 36% from Rs.193 crore in FY2009 to Rs.262
crore in FY2014, its net profits has grown little more than 3-fold from Rs.1.63 crore to Rs.7.11 crore during the
same period.
Cheaply valued FMCG stock, reporting consistent & improving numbers & performance
Bambino is one of the cheaply valued FMCG stocks (trades at 1.4x FY2014 EPS of Rs.8.56) with good brand
reputation in the domestic and overseas markets. Bambino has reported total income from operations of Rs.61.45
crore and a net profit of Rs.1.60 crore for the quarter ended Dec 2014.
Innovative range of products with global reach
From its ongoing efforts, Bambino has introduced an innovative range of products such as Spaghetti, Macaroni, and
Instant Pasta besides Indian Ethnic Food like spices, instant food mix, ready to eat sweets, snacks, soups powders, and
hing (compounded asafoefida) as value-added products to the already existing product line. At present, Bambino has
more than 74 prestigious products in variant styles, tastes & types and varieties. Its products are being
exported to various countries including USA, Canada, Australia, New Zealand, South East Asia, Middle East, Far
East, Japan & Africa. The decades of experience in Indian palate, understanding the global consumer
preferences, most modern machinery and large production capacity enriched the company to establish wide
international network and global reach to be a reliable business partner;
Pressure on Wheat prices to help improve margins
The global wheat prices are turning bearish due to surplus wheat production globally, which will lead to unlikely
pickup in the exports from India. This will pile up the inventory levels with the domestic producers which will put
pressure on the prices. As the company is in a segment which is more dependent on wheat flour for its products,
the pressure on the wheat prices will result in lower procurement cost to the company and hence will help
improving margins going forward;
Looking to reposition itself as a food – healthcare organization
As a pioneer in the vermicelli & pasta industry, Bambino is looking at future to reposition itself as a food healthcare
organization. With this objective, the company has strengthened its R&D by identifying lifestyle diseases and
developing traditional food of India, which also has health benefits. In order to establish that the product has got
proper certification, it is being tested in reputed institutions & hospitals by clinical trials, to ensure what we claim will
be in the final product. This will definitely enhances the value of the brand to enter a unique area of lifestyle diseases
and giving them suitable solutions, without having side effects. This will also broaden the company’s spectrum of
distribution to new channels like chemists, hospitals and other wellness stores. This will not only help the
company to grow further but also bestow good profits. This will transform Bambino into a trans-national company
with functional foods;
Equinomics Research & Advisory Private Ltd | For private circulation only
Outlook and Valuation
In our view, Bambino is a niche company in the small cap space which is set to emerge as a reasonable-sized FMCG
company in the long term. It is a deep-value stock and we expect the stock to move up to Rs.170/ in 12 to 18 months
timeframe, based on 15x FY2016E EPS of Rs.11.33. In the long term, this stock has a potential to emerge as a multibagger. Hence, we suggest our investors to buy Bambino Agro Industries at the current market price of Rs.114.50/.
Product suitability: This is a deep-value stock in the small cap space. Stocks in this space many times disappoint the
investors in the short to medium terms. It is unlikely to move along with the broader indices and in fact, it may underperform them in the short to medium terms. Hence, this stock is suitable for only for those investors, who are
very long term investors and also can take a significant amount of risk;
Disclosure: I, G.Chokkalingam, do not hold the shares of Bambino directly or indirectly through friends, relatives or
any proxies;
Equinomics
Morning
Insight
| Equinomics Research & Advisory Private Ltd
Morning
Insight
Stock Disclosure: Whether Stock Held By:
Bambino Agro Industries Ltd.
G.Chokkalingam & Family
Equinomics
NO
NO

Equinomics Research & Advisory Private Ltd
Investment Adviser
CIN:U67190MH2014PTC252252
SEBI REG. NO. INA000001712
G. Chokkalingam - Founder & Managing Director
Head Office – Mumbai
18 - A/3, Ekta CHS, Shivdham Complex, Opposite Fire Brigade,
Near Oberoi Mall, Malad (East), Mumbai - 400097
Ph: +91 22 28492940 | Email: [email protected] | Website : www.equinomics.in
Equinomics Research & Advisory Private limited (Equinomics) is a SEBI registered Investment Advisor. This document has been prepared
by Equinomics Research & Advisory Private Ltd– Advisory Client Group. Besides, Equinomics is also Authorised person of Tata Securities
Limited (TSL). TSL or Equinomics Research & Advisory Private Ltd focused-broking division may have issued other reports that are
inconsistent with and reach different conclusion from the information presented in this report. The views and opinions expressed in this
document may or may not match or may be contrary with the views, estimates, rating and target price of the Affiliates research report.
The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in
any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without
prior written consent.
This report and information herein is solely for informational purpose and may not be used or considered as an offer document or
solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Nothing in this report constitutes investment,
legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific
circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their
own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be
taken in substitution for the exercise of independent judgement by any recipient.
Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an
investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own
advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all
investors. Certain transactions -including those involving futures, options and other derivatives as well as non investment grade securities
- involve substantial risk and are not suitable for all investors.
Equinomics has not independently verified all the information given in this document. Accordingly, no representation or warranty, express
or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this document.
The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be
treated as endorsement of the views expressed in the report. This information is subject to change without any prior notice. The Company
reserves the right to make modifications and alternations to this statement as may be required from time to time without any prior
approval.
Equinomics Research & Advisory Private Ltd, its affiliates, their directors and the employees may from time to time, effect or have effected
an own account transaction in, or deal as principal or agent in or for the securities mentioned in this document. They may perform or seek
to perform investment banking or other services for, or solicit investment banking or other business from, any company referred to in this
report. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this into account
before interpreting the document.
This report has been prepared on the basis of information that is already available in publicly accessible media or developed through
analysis of Equinomics. The views expressed are those of the analyst and the Company may or may not subscribe to all the views expressed
therein.
This document is being supplied to you solely for your information and may not be reproduced, redistributed or passed on, directly or
indirectly, to any other person or published, copied, in whole or in part, for any purpose.
Neither this document nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or
distributed, directly or indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any
locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or
which would subject Equinomics Research & Advisory Private Ltd to any registration or licensing requirement within such jurisdiction.
The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose
possession this document may come are required to inform them of and to observe such restriction.
Neither the Firm, not its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect,
incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the
information.
Equinomics
Research
& Advisory
Private
Limited
- Investment
Adviser
Copyright
of this document
vests exclusively
with Equinomics
Research
& Advisory
Private Ltd.